Latest Breaking News On - Taro pharmaceutical industrie - Page 1 : comparemela.com

Sun Pharma to pursue M&A, licensing to expand speciality business

Sun Pharma to pursue M&A, licensing to expand speciality business
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

United statesSun pharmaAbhay gandhiNorth america businessTaro pharmaceutical industrieExpand specialityConcert pharma

Sensex, Nifty Rise After US Debt Deal

Indian shares opened on a positive note Monday after U.S. lawmakers announced a tentative deal to raise the federal government's debt ceiling and avert a devasting default.

Sun pharmaceutical industriesIndusind bankPower finance corpFinance corpPharmaceutical industriesTaro pharmaceutical industrieNdian shares

Sun Pharma Q4 results: Consolidated PAT rises 123% YoY to Rs 894 cr, misses estimates; board to pay Rs 2 dividend

›Sun Pharma Q4 results: Consolidated PAT rises 123% YoY to Rs 894 cr, misses estimates; board to pay Rs 2 dividend Sun Pharma Q4 results: Consolidated PAT rises 123% YoY to Rs 894 cr, misses estimates; board to pay Rs 2 dividend SECTIONS Sun Pharma Q4 results: Consolidated PAT rises 123% YoY to Rs 894 cr, misses estimates; board to pay Rs 2 dividendETMarkets.com Last Updated: May 27, 2021, 04:45 PM IST Share Synopsis The big miss on the bottomline by the company was a result of an exceptional loss worth Rs 672.8 crore related to various litigation settlements pertaining to some of its subsidiaries. The company’s consolidated revenue from operations rose merely 4 per cent on-year to Rs 8,523 crore, which was also below analysts’ expectations of Rs 8,712.5 crore.

Sun pharmaceutical industriesUs department of justiceTaro pharmaceutical industrieNet profitEarnings estimatesQ4 earningsSun pharmaceuticalsசூரியன் மருந்து தொழில்கள்எங்களுக்கு துறை ஆஃப் நீதிநிகர ப்ராஃபிட்சூரியன் மருந்துகள்